Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 76 - 85 of 85 in total
Sus scrofa placenta is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Synonyms: … Pork Placenta …
Matched Name: … Sus scrofa placenta …
Matched Description: … Sus scrofa placenta is an animal extract used in some OTC (over-the-counter) products. …
Experimental
Matched Synonyms: … Pork, stomach …
Matched Name: … Sus scrofa stomach …
Isoquercetin has been used in trials studying the treatment of Kidney Cancer, Renal cell carcinoma, Advanced Renal Cell Carcinoma, Thromboembolism of Vein in Pancreatic Cancer, and Thromboembolism of Vein VTE in Colorectal Cancer, among others.
Investigational
Matched Description: … in Pancreatic Cancer, and Thromboembolism of Vein VTE in Colorectal Cancer, among others. ... treatment of Kidney Cancer, Renal cell carcinoma, Advanced Renal Cell Carcinoma, Thromboembolism of Vein
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Aminaftone has been investigated for the treatment of Cockett Syndrome, May-Thurner Syndrome, and Iliac Vein Obstruction.
Investigational
Matched Description: … Aminaftone has been investigated for the treatment of Cockett Syndrome, May-Thurner Syndrome, and Iliac Vein
Nona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs (PATENT)).
Investigational
Matched Description: … Nona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs …
LJP 1082 is a Toleragen that is designed to shut down the B cells that produce antibodies to ß2 GP1. LJP 1082 is undergoing trial for for the treatment of stroke, deep-vein thrombosis and other conditions associated with antibody-mediated thrombosis. Antibody-mediated thrombosis, also called antiphospholipid syndrome (APS), is a blood...
Investigational
Matched Iupac: … 2-amino-4-({1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl}carbamoyl)butanoic acid …
Matched Description: … The target of the LJP 1082's clot-promoting antibodies is a small region on a key blood protein called ... LJP 1082 is undergoing trial for for the treatment of stroke, deep-vein thrombosis and other conditions ... high levels of anticardiolipin antibodies (ACA) have an increased risk of stroke, heart attack, deep vein
Invert sugar is obtained from sugar cane when this is treated with dilute acid or with the invertase enzyme. It is formed by an equal amount of glucose and fructose. It differentiates from sugar cane in the rotation of the polarized light, which in the case of invert sugar it...
Experimental
Recombinant nematode anticoagulant protein c2 (rNAPc2) is a specific inhibitor of tissue factor (TF)/factor VIIa complex with novel antithrombotic activity.
Investigational
Taberminogene vadenovec (EG004) is a novel product consisting of a local delivery device and a gene-based medicine, being developed to prevent the blocking of veins and arteries that frequently occurs after vascular surgery. The initial target market is haemodialysis graft access surgery, a procedure in which patients whose kidneys have...
Investigational
Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione class. Ciglitazone was never used as a medication, but it sparked interest in the effects of thiazolidinediones. Several analogues were later developed, some of which—such as pioglitazone and troglitazone—made it to the market....
Experimental
Matched Iupac: … 5-({4-[(1-methylcyclohexyl)methoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione …
Matched Description: … It is also an anti-hyperglycemic agent in the ob/ob murine model in vivo. ... endothelial cell (HUVEC), and osteoblastogenesis in human mesenchymal stem cells. ... Ciglitazone increases adipogenesis, decreases differentiation and angiogenesis in human umbilical vein
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Displaying drugs 76 - 85 of 85 in total